scispace - formally typeset
S

Shin-ichi Muramatsu

Researcher at Jichi Medical University

Publications -  189
Citations -  6916

Shin-ichi Muramatsu is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Dopamine & Adeno-associated virus. The author has an hindex of 40, co-authored 165 publications receiving 5972 citations. Previous affiliations of Shin-ichi Muramatsu include Meijo University & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Electrophysiological study of dyskinesia produced by microinjection of picrotoxin into the striatum of the rat.

TL;DR: The neuronal mechanism of dyskinesia of the contralateral forelimb produced by microinjection of picrotoxin into the caudoputaminal unit (CPU) was analyzed electrophysiologically and it is proposed that the primary origin of the dyskinisia is the CPU and that the inhibitory CPU efferent, as well as the nigrothalamic, pathway plays a basic role in the manifestation of the Dyskineia.
Journal ArticleDOI

Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice

TL;DR: Results indicate that Shati/Nat8l in the NAc, but not in the dS, plays an important suppressive role in the behavioral responses to METH by controlling the dopaminergic system via activation of group II mGluRs.
Journal ArticleDOI

Regulation of the dopaminergic system in a murine model of aromatic l-amino acid decarboxylase deficiency

TL;DR: An AADC deficient mouse model is generated, in which compensatory regulation allowed the mice to survive to adulthood and will be useful both for developing gene therapies for A ADC deficiency and for designing treatments for diseases associated with neurotransmitter deficiency.
Journal ArticleDOI

Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.

TL;DR: Pathological hyperechogenic alterations in the SN in patients with iRBD may suggest the existence of preclinical SN dysfunction as determined by FMT-PET.